These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 19778160)
1. Chemical stability of 4'-azidocytidine and its prodrug balapiravir. Li F; Wu X; Hadig X; Huang S; Hong L; Tran T; Brandl M; Alfredson T Drug Dev Ind Pharm; 2010 Apr; 36(4):413-20. PubMed ID: 19778160 [TBL] [Abstract][Full Text] [Related]
2. Activation of peripheral blood mononuclear cells by dengue virus infection depotentiates balapiravir. Chen YL; Abdul Ghafar N; Karuna R; Fu Y; Lim SP; Schul W; Gu F; Herve M; Yokohama F; Wang G; Cerny D; Fink K; Blasco F; Shi PY J Virol; 2014 Feb; 88(3):1740-7. PubMed ID: 24257621 [TBL] [Abstract][Full Text] [Related]
3. Robust antiviral activity of R1626, a novel nucleoside analog: a randomized, placebo-controlled study in patients with chronic hepatitis C. Roberts SK; Cooksley G; Dore GJ; Robson R; Shaw D; Berns H; Hill G; Klumpp K; Najera I; Washington C Hepatology; 2008 Aug; 48(2):398-406. PubMed ID: 18553458 [TBL] [Abstract][Full Text] [Related]
4. Physicochemical properties of the nucleoside prodrug R1626 leading to high oral bioavailability. Brandl M; Wu X; Holper M; Hong L; Jia Z; Birudaraj R; Reddy M; Alfredson T; Tran T; Larrabee S; Hadig X; Sarma K; Washington C; Hill G; Smith DB Drug Dev Ind Pharm; 2008 Jul; 34(7):683-91. PubMed ID: 18612909 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and antiviral properties of 4'-substituted ribonucleosides as inhibitors of hepatitis C virus replication: the discovery of R1479. Smith DB; Martin JA; Klumpp K; Baker SJ; Blomgren PA; Devos R; Granycome C; Hang J; Hobbs CJ; Jiang WR; Laxton C; Le Pogam S; Leveque V; Ma H; Maile G; Merrett JH; Pichota A; Sarma K; Smith M; Swallow S; Symons J; Vesey D; Najera I; Cammack N Bioorg Med Chem Lett; 2007 May; 17(9):2570-6. PubMed ID: 17317178 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogs. Jin Z; Kinkade A; Behera I; Chaudhuri S; Tucker K; Dyatkina N; Rajwanshi VK; Wang G; Jekle A; Smith DB; Beigelman L; Symons JA; Deval J Antiviral Res; 2017 Jul; 143():151-161. PubMed ID: 28412183 [TBL] [Abstract][Full Text] [Related]
8. 4'-Azidocytidine (R1479) inhibits henipaviruses and other paramyxoviruses with high potency. Hotard AL; He B; Nichol ST; Spiropoulou CF; Lo MK Antiviral Res; 2017 Aug; 144():147-152. PubMed ID: 28629988 [TBL] [Abstract][Full Text] [Related]
9. The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479). McGuigan C; Kelleher MR; Perrone P; Mulready S; Luoni G; Daverio F; Rajyaguru S; Le Pogam S; Najera I; Martin JA; Klumpp K; Smith DB Bioorg Med Chem Lett; 2009 Aug; 19(15):4250-4. PubMed ID: 19505826 [TBL] [Abstract][Full Text] [Related]
10. R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin. Pockros PJ; Nelson D; Godofsky E; Rodriguez-Torres M; Everson GT; Fried MW; Ghalib R; Harrison S; Nyberg L; Shiffman ML; Najera I; Chan A; Hill G Hepatology; 2008 Aug; 48(2):385-97. PubMed ID: 18570306 [TBL] [Abstract][Full Text] [Related]
11. Susceptibility of paramyxoviruses and filoviruses to inhibition by 2'-monofluoro- and 2'-difluoro-4'-azidocytidine analogs. Lo MK; Jordan PC; Stevens S; Tam Y; Deval J; Nichol ST; Spiropoulou CF Antiviral Res; 2018 May; 153():101-113. PubMed ID: 29601894 [TBL] [Abstract][Full Text] [Related]
12. Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years. Sinokrot H; Smerat T; Najjar A; Karaman R Molecules; 2017 Oct; 22(10):. PubMed ID: 29035325 [No Abstract] [Full Text] [Related]
13. Stability of valacyclovir: implications for its oral bioavailability. Granero GE; Amidon GL Int J Pharm; 2006 Jul; 317(1):14-8. PubMed ID: 16759825 [TBL] [Abstract][Full Text] [Related]
14. Kinetic studies of the degradation of oxycarbonyloxymethyl prodrug of Adefovir and Tenofovir in solution. Oliyai R; Yuan LC; Dahl T Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1295-8. PubMed ID: 11563007 [TBL] [Abstract][Full Text] [Related]
15. Cyclic phosphoramidates as prodrugs of 2'-C-methylcytidine. Meppen M; Pacini B; Bazzo R; Koch U; Leone JF; Koeplinger KA; Rowley M; Altamura S; Di Marco A; Fiore F; Giuliano C; Gonzalez-Paz O; Laufer R; Pucci V; Narjes F; Gardelli C Eur J Med Chem; 2009 Sep; 44(9):3765-70. PubMed ID: 19493593 [TBL] [Abstract][Full Text] [Related]
16. In vitro selected Con1 subgenomic replicons resistant to 2'-C-methyl-cytidine or to R1479 show lack of cross resistance. Le Pogam S; Jiang WR; Leveque V; Rajyaguru S; Ma H; Kang H; Jiang S; Singer M; Ali S; Klumpp K; Smith D; Symons J; Cammack N; Nájera I Virology; 2006 Aug; 351(2):349-59. PubMed ID: 16713611 [TBL] [Abstract][Full Text] [Related]
17. Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs. Luo M; Groaz E; Andrei G; Snoeck R; Kalkeri R; Ptak RG; Hartman T; Buckheit RW; Schols D; De Jonghe S; Herdewijn P J Med Chem; 2017 Jul; 60(14):6220-6238. PubMed ID: 28682067 [TBL] [Abstract][Full Text] [Related]
18. A stability-indicating HPLC assay with diode array detection for the determination of a benzylpenicillin prodrug in aqueous solutions. Jain R; Wu Z; Tucker IG J Pharm Biomed Anal; 2009 Dec; 50(5):841-6. PubMed ID: 19640667 [TBL] [Abstract][Full Text] [Related]
19. Potential improvement in the shelf life of parenterals using the prodrug approach: bacampicillin and talampicillin hydrolysis kinetics and utilization time. Nguyen NA; Mortada LM; Notari RE Pharm Res; 1988 May; 5(5):288-96. PubMed ID: 3244638 [TBL] [Abstract][Full Text] [Related]